Unknown

Dataset Information

Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients.


ABSTRACT:

Introduction

Fractalkine is a chemokine implicated as a mediator in a variety of inflammatory conditions. Knowledge of fractalkine release in patients presenting with infection to the Intensive Care Unit (ICU) is highly limited. The primary objective of this study was to establish whether plasma fractalkine levels are elevated in sepsis and associate with outcome. The secondary objective was to determine whether fractalkine can assist in the diagnosis of infection upon ICU admission.

Methods

Fractalkine was measured in 1103 consecutive sepsis patients (including 271 patients with community-acquired pneumonia (CAP)) upon ICU admission and at days 2 and 4 thereafter; in 73 ICU patients treated for suspected CAP in whom this diagnosis was refuted in retrospect; and in 5 healthy

SUBMITTER: Hoogendijk AJ 

PROVIDER: S-EPMC4658804 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature